Sun Pharmaceutical Industries Limited
SUNPHARMA
株式のランク
#525
Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical... Sun Pharmaceutical Industries Limited, a leading generic pharmaceutical enterprise, is dedicated to the research, development, production, and marketing of both proprietary and unbranded medicinal formulations, alongside active pharmaceutical ingredients (APIs), for distribution across India and international markets. Its extensive product range encompasses treatments for numerous therapeutic fields, including central nervous system disorders, dermatological conditions, cardiovascular diseases, oncology, ophthalmic care, neuropsychiatry, gastrointestinal issues, infectious diseases, diabetes management, pain relief, nutritional supplements, respiratory ailments, gynaecology, urology, orthopaedics, nephrology, and dental health, among others. The company additionally provides APIs crucial for the creation of anti-cancer drugs, peptides, steroids, sex hormones, and controlled substances. Its generic medications are available in various forms, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquid preparations. Furthermore, Sun Pharma develops specialized medications and a variety of over-the-counter health products. The company was established in 1983 and operates from its headquarters in Mumbai, India.
株価
$19.24
時価総額
$46.15B
変化（1日）
-0.97%
変化（1年）
0.84%
国
IN
取引 Sun Pharmaceutical Industries Limited (SUNPHARMA)
カテゴリー
Healthcare
Sun Pharmaceutical Industries Limited（SUNPHARMA）の営業利益率
October 2026 時点の営業利益率 TTM: 22.93%
Sun Pharmaceutical Industries Limited の最新の財務報告と株価によると、現在の営業利益率（TTM）は 22.93% です。2024 年末時点では 50.36% でした。
Sun Pharmaceutical Industries Limited の営業利益率の履歴（2004 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 22.93% | -56.65% |
| 2025 | 52.90% | 5.04% |
| 2024 | 50.36% | 0.90% |
| 2023 | 49.91% | 5.47% |
| 2022 | 47.32% | 3.79% |
| 2021 | 45.59% | 0.93% |
| 2020 | 45.17% | 3.65% |
| 2019 | 43.58% | 3.81% |
| 2018 | 41.98% | -17.15% |
| 2017 | 50.67% | -2.52% |
| 2016 | 51.98% | 3.40% |
| 2015 | 50.27% | 17.76% |
| 2014 | 42.69% | -1.45% |
| 2013 | 43.32% | 16.67% |
| 2012 | 37.13% | 4.36% |
| 2011 | 35.58% | -1.82% |
| 2010 | 36.24% | -20.56% |
| 2009 | 45.62% | -4.26% |
| 2008 | 47.65% | 21.90% |
| 2007 | 39.09% | 7.18% |
| 2006 | 36.47% | 3.81% |
| 2005 | 35.13% | -9.27% |
| 2004 | 38.72% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 0.00% | - |
CH
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。